Capital Gp IX Llc Orbimed serves as Executive at Shattuck Labs, Inc., where they oversee executive responsibilities. Since joining the company, Capital Gp IX Llc Orbimed has executed 2 insider transactions totaling $5.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 25, 2025 involved purchasing 1,051,021 shares valued at $914.4K.
Capital Gp IX Llc Orbimed currently holds 1,051,021 shares of Shattuck Labs, Inc. (STTK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Gp IX Llc Orbimed has been a net buyer of STTK stock. They have purchased $5.5M and sold $0 worth of shares.
Capital Gp IX Llc Orbimed's most recent insider trade was on Aug 25, 2025, when they purchased 1,051,021 shares at $0.87 per share.
Get notified when new Form 4 filings are submitted
| $0.87 |
| Discretionary |